Science Explorer Back to mapMap
Discussion
Researcher · NKT Therapeutics (United States) · United States

Robert D. Mashal

Robert D. Mashal publishes mostly in Immunology, Molecular Biology and Cellular and Molecular Neuroscience, on topics such as Immune Cell Function and Interaction, T-cell and B-cell Immunology and Chronic Myeloid Leukemia Treatments.

OpenAlex
World rank
#1,163,775
of 7,710,434 ranked researchers
Rank in United States
#374,378
of 1,627,098
Works
32
Citations
1.8k
Citations per work
57.0
h-index
20
i10-index 21Top 31% in Immunology
Robert D. Mashal

What does Robert D. Mashal research?

Robert D. Mashal's work is mostly in Immunology and Microbiology (24%), Biochemistry, Genetics and Molecular Biology (18%), Medicine (18%).

Life Sciences: 16 works · 50.6% of their workImmunology and Microbiology: 8 works · 23.6% of their workImmunology: 8 works · 23.6% of their workBiochemistry, Genetics and Molecular Biology: 6 works · 18.0% of their workMolecular Biology: 6 works · 18.0% of their workNeuroscience: 3 works · 9.0% of their workCellular and Molecular Neuroscience: 3 works · 9.0% of their workEverything else: 10 works · 31.5% of their workHealth Sciences: 6 works · 17.9% of their workMedicine: 6 works · 17.9% of their workHematology: 2 works · 6.7% of their workGenetics: 2 works · 5.6% of their workOncology: 2 works · 5.6% of their workTHEIR WORKRobert D. Mashal32works
Life Sciences51%Health Sciences18%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology823.6%
    2. Biochemistry, Genetics and Molecular Biology618.0%
    3. Neuroscience39.0%
  2. Everything else1031.5%
    1. Medicine617.9%
  1. 1Immunology24% of their works
  2. 2Molecular Biology18% of their works
  3. 3Cellular and Molecular Neuroscience9% of their works
  4. 4Hematology7% of their works
  5. 5Genetics6% of their works
  6. 6Oncology6% of their works

Research topics

Which keywords describe Robert D. Mashal's research?

The keywords of their largest research topics: Natural Killer Cells, NK Cell Recognition, BCR-ABL, Foxp3, Imatinib, TGF-ß, Crystal Structure and G-Protein-Coupled Receptors.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 16 words, with their numbers
  1. NK Cell Recognition111 topic
  2. Natural Killer Cells111 topic
  3. BCR-ABL51 topic
  4. Foxp351 topic
  5. Imatinib51 topic
  6. TGF-ß51 topic
  7. Crystal Structure41 topic
  8. G-Protein-Coupled Receptors41 topic
  9. Neurotransmission41 topic
  10. Sickle-cell Disease41 topic
  11. Synaptic Plasticity41 topic
  12. Thalassemia41 topic
  13. AIDS21 topic
  14. Cancer Genomics21 topic
  15. HIV21 topic
  16. Mutational Signatures21 topic

Where does Robert D. Mashal work?

Robert D. Mashal's main affiliation in the publication record is NKT Therapeutics (United States), United States.

How many publications and citations does Robert D. Mashal have?

OpenAlex counts 32 works and 1,824 citations for Robert D. Mashal, an h-index of 20, ranking #1,163,775 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Robert D. Mashal. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.